Takeda Pharmaceutical TAK
NYSE TAK
$17.81 -0.05 (-0.28%)
As of: Oct 2, 2026 · 12:45 PM EDT

Takeda Pharmaceutical (TAK) Change in Working Capital (2022 - 2026)

Updated

Takeda Pharmaceutical (TAK) recorded Change in Working Capital of -$811.73 million in the quarter ended Mar 31, 2026, compared with $671.85 million a year earlier.

Analysis

Takeda Pharmaceutical (TAK) Change in Working Capital (2022 - 2026) Analysis & Trends

On a TTM basis, Takeda Pharmaceutical's Change in Working Capital came in at -$1.89 billion as of Mar 31, 2026.

  • The figure for the quarter ended Mar 31, 2026 is the lowest quarterly Change in Working Capital since the quarter ended Sep 30, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -423.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 232.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.82 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -811.73 Mn
Sep 30, 2025 -627.78 Mn
Mar 31, 2025 671.85 Mn
Sep 30, 2024 -1.12 Bn
Mar 31, 2024 -1.04 Bn
Sep 30, 2023 -1.19 Bn
Mar 31, 2023 -1.16 Bn
Sep 30, 2022 -1.25 Bn
API Access

Takeda Pharmaceutical Change in Working Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-working-capital&ticker=TAK&period=max&api_key=YOUR_API_KEY